Clinical Trials Directory

Trials / Unknown

UnknownNCT04429737

The Effects of Freshwater Clam Extract on Blood Sugar, and Lipid Profile in Prediabetes Patients

Department of Traditional Chinese Medicine, Keelung Chang Gung Memorial Hospital

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the freshwater clam extract and its combination is effective on the improvement of glucose and lipid metabolism, also evaluate its ability to postpone prediabetes patients to become diabetes.

Detailed description

This study aims to evaluate the effect of freshwater clam extract and its combination is effective on the improvement of glucose and lipid metabolism, as well as evaluate its ability to postpone prediabetes patients to become diabetes., 3 month and 6 month data will be collected and put into analysis to provide some suggestions on the Clam protein capsules and Clam peptide plus Chlorella capsules use in the clinical practice for prediabetes patients.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTclam protein capsulesThe prediabetes patients in this arm will receive Clam protein capsules with a dose for 2g/d (500mg/capsule, 2 capsules/time, 2 times/day at day and night ) for 6 months ( Blood draw every 3 months) . After taking tested substance 6 months, the prediabetes patients will be continuous tracked for 3 years and be blood drawed every 6 months.
DIETARY_SUPPLEMENTClam peptide plus Chlorella capsulesThe prediabetes patients in this arm will receive Clam peptide plus Chlorella capsules with a dose for 2g/d (500mg/capsule, 2 capsules/time, 2 times/day at day and night ) for 6 months ( Blood draw every 3 months) . After taking tested substance 6 months, the prediabetes patients will be continuous tracked for 3 years and be blood drawed every 6 months.
DIETARY_SUPPLEMENTPlaceboThe prediabetes patients in this arm will receive Placebo with a dose for 2g/d (500mg/capsule, 2 capsules/time, 2 times/day at day and night ) for 6 months ( Blood draw every 3 months) . After taking tested substance 6 months, the prediabetes patients will be continuous tracked for 3 years and be blood drawed every 6 months.

Timeline

Start date
2017-03-01
Primary completion
2022-03-01
Completion
2022-03-01
First posted
2020-06-12
Last updated
2020-06-12

Locations

2 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04429737. Inclusion in this directory is not an endorsement.